Effect of environmental conditions (pH, oxygenation and temperature) on the cytotoxicity of flavone acetic acid and its dimethylaminoethyl ester

References

• Aisenberg A. C., Morris H. P. Energy pathways of hepatoma No. 5123. Nature 1961; 191: 1314–1315
   Google Scholar
• Ambrose A. M., Robbins D. J., DeEds F. Comparative toxicities of Quercetin and Quercitrin. Journal of the American Pharmaceutical Association 1952; 41: 119–122
   Google Scholar
• Atassi G., Briet P., Berthelon J.-J., Collonges F. Synthesis and antitumour activity of some 8-substituted 4-oxo-4H-1-benzopyrans. European Journal of Medicinal Chemistry 1985; 5: 393–402
   Google Scholar
• Bakker-Grunwald T., Andrew J. S., Neville M. C. K+ influx components in ascites cells: the effects of agents interacting with the (Na+-K+)-pump. Journal of Membrane Biology 1980; 52: 141–146
   Google Scholar
• Belt J. A., Thomas J. A., Buchsbaum R. N., Racker E. Inhibitions of lactate transport and glycolysis in Ehrlich ascites tumor cells by bioflavonoids. Biochemistry 1979; 18: 3506–3511
   PubMed Web of Science ®Google Scholar
• Bentsath A., Rusznayak I., Szent-Gyorgyi A. Vitamin nature of flavones. Nature (London) 1936; 138: 798
   Google Scholar
• Bibby M. C., Double J. A., Loadman P. M., Duke C. V. Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy. Journal of the National Cancer Institute 1989; 81: 216–220
   PubMed Web of Science ®Google Scholar
• Bruckner V., Szent-Gyorgyi A. Chemical nature of citrin. Nature (London) 1936; 138: 1057
   Google Scholar
• Burk D., Woods M., Hunter J. On the significance of glycolysis for cancer growth, with special reference to Morris rat hepatomas. Journal of the National Cancer Institute 1967; 38: 839–863
   PubMedGoogle Scholar
• Chaplin D. J., Acker B. The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gain. International Journal of Radiation Oncology, Biology and Physics 1987; 13: 579–585
   PubMed Web of Science ®Google Scholar
• Chaplin D. J., Durand R. E., Olive P. L. Cell selection from a murine tumor using the fluorescent probe Hoechst 33342. British Journal of Cancer 1985; 51: 569–575
   PubMedGoogle Scholar
• Ching L. M., Baguley B. C. Induction of natural killer cell activity by the antitumour compound flavone acetic acid (NSC 347512). European Journal of Cancer and Clinical Oncology 1987; 23: 1047–1050
   PubMedGoogle Scholar
• Ching L. M., Baguley B. C. Enhancement of in vitro cytotoxicity of mouse peritoneal exudate cells by flavone acetic acid (NSC 347512). European Journal of Cancer and Clinical Oncology 1988; 24: 1521–1525
   PubMedGoogle Scholar
• Ching L. M., Baguley B. C. Reduction of cytotoxic effector cell activity in colon 38 tumours following treatment with Flavone acetic acid. European Journal of Cancer and Clinical Oncology 1989a; 25: 1061–1065
   Google Scholar
• Ching L. M., Baguley B. C. Effect of Flavone acetic acid (NSC 347512) on splenic cytotoxic effector cells and their role in tumour necrosis. European Journal of Cancer and Clinical Oncology 1989b; 25: 821–828
   PubMedGoogle Scholar
• Corbett T. H., Bissery M. C., Wozniak A., Plowman J., Polin L., Tapazoglou E., Dieckman J., Valeriote F. Activity of flavone acetic acid (NSC 347512) against solid tumors in mice. Investigative New Drugs 1986; 4: 207–220
   PubMed Web of Science ®Google Scholar
• Finlay G. J., Smith G. P., Fray L. M., Baguley B. C. Effect of flavone acetic acid (NSC 347512) on Lewis lung carcinoma; evidence for an indirect effect. Journal of the National Cancer Institute 1988; 80: 241–245
   PubMed Web of Science ®Google Scholar
• The Flavonoids, J. B. Harborne, T. J. Mabry, H. Mabry. Academic Press, New York 1975
   Google Scholar
• Herman T. S., Teicher B. A. Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma. Cancer Research 1988; 48: 2693–2697
   PubMed Web of Science ®Google Scholar
• Herman T. S., Sweets C. C., White D. M., Gerner E. W. Effect of heating on lethality due to hyperthermia and selected chemotherapeutic drugs. Journal of the National Cancer Institute 1982; 68: 487–491
   PubMedGoogle Scholar
• Herman T. S., Teicher B. A., Collins L. S. Effect of hypoxia and acidosis on the cytotoxicity of four platinum complexes at normal and hyperthermia temperatures. Cancer Research 1988; 48: 2342–2347
   PubMed Web of Science ®Google Scholar
• Herman T. S., Teicher B. A., Holden S. A. Trimodality Therapy (Drug/Hyperthermia/Radiation) with BCNU or Mitomycin C. International Journal of Radiation Oncology, Biology and Physics 1990; 18: 375–382
   PubMed Web of Science ®Google Scholar
• Herman T. S., Teicher B. A., Holden S. A., Collins L. S. Interaction of hyperthermia and radiation: hypoxia and acidosis in vitro, tumor subpopulations in vivo. Cancer Research 1989; 49: 3338–3343
   PubMed Web of Science ®Google Scholar
• Herman T. S., Teicher B. A., Holden S. A., Rudolph M., Coleman C. N. The interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo. Cancer Research 1990; 50: 5055–5059
   PubMed Web of Science ®Google Scholar
• Lang D. R., Racker E. Effects of Quercetin an F1 inhibitor of mitochondrial ATPase and energy-linked reactions in submitochondrial particles. Biochimica et Biophysica Acta 1974; 333: 180–186
   PubMedGoogle Scholar
• Old L. J. Tumour necrosis factor (TNF). Science 1985; 230: 630–633
   PubMed Web of Science ®Google Scholar
• Plowman J., Narayanan V. L., Dykes D., Szarvasi E., Briet P., Yoder O. C., Paull K. D. Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice. Cancer Treatment Reports 1986; 70: 631–635
   PubMedGoogle Scholar
• Racker E. Bioenergetics and the problem of tumor growth. American Scientist 1972; 60: 56–63
   PubMed Web of Science ®Google Scholar
• Racker E. Why do tumor cells have a high aerobic glycolysis. Journal of Cell Physiology 1975; 89: 697–700
   Google Scholar
• Racker E. A New Look at Mechanisms in Bioenergetics. Academic Press, New York 1976
   Google Scholar
• Rice L., Urano M., Suit H. D. The radiosensitivity of a murine fibrosarcoma as measured by three cell survival assays. British Journal of Cancer 1980; 41: 240–245
   Web of Science ®Google Scholar
• Siemann D. W., Keng P. C. Characterization of radiation resistant hypoxic cell subpopulations in KHT sarcomas. II. Cell sorting. British Journal of Cancer 1988; 58: 296–300
   PubMedGoogle Scholar
• Smith G. P., Calveley S. B., Smith M. J., Baguley B. C. Flavone acetic acid (NSC 347512) induces haemorrhagic necrosis of mouse colon 26 and 38 tumours. European Journal of Cancer and Clinical Oncology 1987; 23: 1209–1211
   PubMedGoogle Scholar
• Sun J.-R., Brown J. M. Enhancement of the antitumor effect of flavone acetic acid by the bioreductive cytotoxic drug SR-4233 in a murine carcinoma. Cancer Research 1989; 49: 5664–5670
   PubMedGoogle Scholar
• Suolinna E.-M., Lang D. R., Racker E. Quercetin, and artificial regulator of the high aerobic glycolysis of tumor cells. Journal of the National Cancer Institute 1974; 53: 1515–1519
   PubMedGoogle Scholar
• Suolinna E.-M., Buchsbaum R. N., Racker E. The effect of flavonoids on aerobic glycolysis and growth of tumor cells. Cancer Research 1975; 35: 1865–1872
   PubMed Web of Science ®Google Scholar
• Teicher B. A., Rose C. M. Perfluorochemical emulsion can increase tumor radiosensitivity. Science 1984; 223: 934–936
   PubMed Web of Science ®Google Scholar
• Teicher B. A., Lazo J. S., Sartorelli A. C. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Research 1981; 41: 73–81
   PubMed Web of Science ®Google Scholar
• Teicher B. A., Herman T. S., Holden S. A. Combined modality therapy with bleomycin/hyperthermia/radiation. Cancer Research 1988; 48: 6291–6297
   PubMed Web of Science ®Google Scholar
• Wiltrout R. H. Systemic augmentation of natural killer (NK) activity by chemotherapeutic drug flavone 8-acetic acid. Proceedings of the American Association for Cancer Research 1987; 28: 347
   Google Scholar
• Zaharko D. S., Grieshaber C. K., Plowman J., Cradock J. C. Therapeutic and pharmacokinetic relationships of flavone acetic acid: an agent with activity against solid tumors. Cancer Treatment Reports 1986; 70: 1415–1421
   PubMedGoogle Scholar
• Zeman E. M., Brown J. M., Lemmon M. J., Hirst V. K., Lee W. W. SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 1239–1242
   PubMed Web of Science ®Google Scholar
• Zeman E. M., Hirst V. K., Lemmon M. J., Brown J. M. Enhancement of radiation-induced tumor cell killing by the hypoxic cell toxin SR-4233. Radiotherapy and Oncology 1988; 12: 209–213
   PubMed Web of Science ®Google Scholar